Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06559995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder

Study acronym: KSAW
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Site details revisedv6 Show 1 more changeShow less
    • Site details revised
  2. Start date: May 2025 to Aug 1, 2025v5
  3. Start date: Mar 2025 to May 2025v4
  4. Start date: Jan 2025 to Mar 2025v3
  5. Primary completion date: Dec 2026 to Dec 2027 Start date: Dec 2024 to Jan 2025v2 Show 1 more changeShow less
    • Start date: Dec 2024 to Jan 2025
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn the effects of ketone supplement compared to placebo on alcohol withdrawal symptoms during a 4 day alcohol withdrawal management treatment in adults with moderate to severe alcohol use disorder at the Hospital of the University of Pennsylvania, Cedar Detox Center.
Trial Details
NCT Number NCT06559995
Lead Sponsor University of Pennsylvania
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Alcohol Use Disorder, Alcohol Withdrawal, Ketosis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov